Vitekta

New Zealand - English - Medsafe (Medicines Safety Authority)

Active ingredient:
Elvitegravir 150 mg;  ;  ;  ;  
Available from:
Gilead Sciences (NZ)
INN (International Name):
Elvitegravir 150 mg
Dosage:
150 mg
Pharmaceutical form:
Film coated tablet
Composition:
Active: Elvitegravir 150 mg         Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry green 85F91203 Sodium laurilsulfate
Prescription type:
Prescription
Manufactured by:
Catalent Micron Technologies Inc
Therapeutic indications:
Indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.
Product summary:
Package - Contents - Shelf Life: Bottle, plastic, HDPE with child resistant PE cap - 30 tablets - 24 months from date of manufacture stored at or below 25°C
Authorization number:
TT50-9425a
Authorization date:
2013-11-04

Similar products

Search alerts related to this product

Share this information